These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30118184)

  • 1. Dissemination of exposure in the treatment of anxiety disorders and post-traumatic stress disorder among German cognitive behavioural therapists.
    Schumacher S; Weiss D; Knaevelsrud C
    Clin Psychol Psychother; 2018 Nov; 25(6):856-864. PubMed ID: 30118184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The German Adaptation of the Therapist Beliefs about Exposure Scale: a Validation Study among Licensed Cognitive Behavioural Therapists in Germany.
    Schumacher S; Schopka NM; Heinrich M; Knaevelsrud C
    Behav Cogn Psychother; 2019 Mar; 47(2):164-180. PubMed ID: 29897024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Struggle of Behavioral Therapists With Exposure: Self-Reported Practicability, Negative Beliefs, and Therapist Distress About Exposure-Based Interventions.
    Pittig A; Kotter R; Hoyer J
    Behav Ther; 2019 Mar; 50(2):353-366. PubMed ID: 30824251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the use of exposure therapy in the treatment of anxiety disorders: a survey among cognitive behavioural therapists in the Netherlands.
    Sars D; van Minnen A
    BMC Psychol; 2015; 3(1):26. PubMed ID: 26246900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure therapy for youth with anxiety: Utilization rates and predictors of implementation in a sample of practicing clinicians from across the United States.
    Reid AM; Guzick AG; Fernandez AG; Deacon B; McNamara JPH; Geffken GR; McCarty R; Striley CW
    J Anxiety Disord; 2018 Aug; 58():8-17. PubMed ID: 29929139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissemination of evidence-based practices for anxiety disorders in Wyoming: a survey of practicing psychotherapists.
    Hipol LJ; Deacon BJ
    Behav Modif; 2013 Mar; 37(2):170-88. PubMed ID: 23012685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults.
    Olthuis JV; Watt MC; Bailey K; Hayden JA; Stewart SH
    Cochrane Database Syst Rev; 2015 Mar; (3):CD011565. PubMed ID: 25742186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing therapist reservations about exposure therapy for anxiety disorders: the Therapist Beliefs about Exposure Scale.
    Deacon BJ; Farrell NR; Kemp JJ; Dixon LJ; Sy JT; Zhang AR; McGrath PB
    J Anxiety Disord; 2013 Dec; 27(8):772-80. PubMed ID: 23816349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors associated with practitioners' use of exposure therapy for childhood anxiety disorders.
    Whiteside SP; Deacon BJ; Benito K; Stewart E
    J Anxiety Disord; 2016 May; 40():29-36. PubMed ID: 27085463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do negative beliefs about exposure therapy cause its suboptimal delivery? An experimental investigation.
    Farrell NR; Deacon BJ; Kemp JJ; Dixon LJ; Sy JT
    J Anxiety Disord; 2013 Dec; 27(8):763-71. PubMed ID: 23602351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Theory-based training strategies for modifying practitioner concerns about exposure therapy.
    Farrell NR; Deacon BJ; Dixon LJ; Lickel JJ
    J Anxiety Disord; 2013 Dec; 27(8):781-7. PubMed ID: 24210013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure Therapy Beliefs and Utilization for Treatment of PTSD: A Survey of Licensed Mental Health Providers.
    Kline AC; Klein AB; Bowling AR; Feeny NC
    Behav Ther; 2021 Jul; 52(4):1019-1030. PubMed ID: 34134819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapists' characteristics associated with the (non-)use of exposure in the treatment of anxiety disorders in youth: A survey among Dutch-speaking mental health practitioners.
    de Jong R; Lommen MJJ; van Hout WJPJ; de Jong PJ; Nauta MH
    J Anxiety Disord; 2020 Jun; 73():102230. PubMed ID: 32428821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is cognitive-behavioural therapy more effective than relaxation therapy in the treatment of anxiety disorders? A meta-analysis.
    Montero-Marin J; Garcia-Campayo J; López-Montoyo A; Zabaleta-Del-Olmo E; Cuijpers P
    Psychol Med; 2018 Jul; 48(9):1427-1436. PubMed ID: 29037266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why do clinicians exclude anxious clients from exposure therapy?
    Meyer JM; Farrell NR; Kemp JJ; Blakey SM; Deacon BJ
    Behav Res Ther; 2014 Mar; 54():49-53. PubMed ID: 24530499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Barriers to the use of exposure therapy by psychologists treating anxiety, obsessive-compuslive disorder, and posttraumatic stress disorder in an Australian sample.
    Moses K; Gonsalvez CJ; Meade T
    J Clin Psychol; 2023 Apr; 79(4):1156-1165. PubMed ID: 36449416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged exposure therapy for post-traumatic stress disorder: a review of evidence and dissemination.
    McLean CP; Foa EB
    Expert Rev Neurother; 2011 Aug; 11(8):1151-63. PubMed ID: 21797656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive weekend group treatment for panic disorder and its impact on co-occurring PTSD: A pilot study.
    Teng EJ; Barrera TL; Hiatt EL; Chaison AD; Dunn NJ; Petersen NJ; Stanley MA
    J Anxiety Disord; 2015 Jun; 33():1-7. PubMed ID: 25942646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of education on clinicians' attitudes to exposure therapy for eating disorders.
    Waller G; D'Souza Walsh K; Wright C
    Behav Res Ther; 2016 Jan; 76():76-80. PubMed ID: 26686264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.
    Mataix-Cols D; Fernández de la Cruz L; Monzani B; Rosenfield D; Andersson E; Pérez-Vigil A; Frumento P; de Kleine RA; Difede J; Dunlop BW; Farrell LJ; Geller D; Gerardi M; Guastella AJ; Hofmann SG; Hendriks GJ; Kushner MG; Lee FS; Lenze EJ; Levinson CA; McConnell H; Otto MW; Plag J; Pollack MH; Ressler KJ; Rodebaugh TL; Rothbaum BO; Scheeringa MS; Siewert-Siegmund A; Smits JAJ; Storch EA; Ströhle A; Tart CD; Tolin DF; van Minnen A; Waters AM; Weems CF; Wilhelm S; Wyka K; Davis M; Rück C; ; Altemus M; Anderson P; Cukor J; Finck C; Geffken GR; Golfels F; Goodman WK; Gutner C; Heyman I; Jovanovic T; Lewin AB; McNamara JP; Murphy TK; Norrholm S; Thuras P
    JAMA Psychiatry; 2017 May; 74(5):501-510. PubMed ID: 28122091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.